GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.05 HKD | -0.65% |
|
-6.73% | -8.96% |
Golden Throat Holdings Group Co Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical, healthcare food and other products. The Company has three products categories that include Golden Throat Lozenges (Over the Counter), which is designed to relieve symptoms of sore and dry throat and hoarse voice caused by acute pharyngitis, Golden Throat Series Products including Dule Lozenges and others, and other products including Yinxingye Tablet, Golden Throat Intestinal Series and others. The Company mainly conducts its business in the domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.96% | 291M | |
| +20.76% | 43.59B | |
| +28.00% | 22.54B | |
| +20.25% | 15.73B | |
| +18.82% | 14.33B | |
| +55.83% | 12.75B | |
| -0.05% | 6.79B | |
| -12.70% | 6.48B | |
| -8.87% | 5.73B | |
| +14.65% | 5.67B |
- Stock Market
- Equities
- 6896 Stock
- News Golden Throat Holdings Group Company Limited
- Golden Throat : Receives $68 Million Go-Private Bid from Singaporean Private Equity Firm
